Gepirone ER regulatory update

FDA’s Psychopharmacologic Drugs Advisory Committee will meet on Dec. 1 to discuss an NDA for gepirone ER from Fabre-Kramer to treat major depressive disorder (MDD). In 2007, the agency issued a not ap...